You just read:

Vanda Receives Negative Opinion for Marketing Authorization from the European Medicines Agency on Fanaptum™ for the Treatment of Schizophrenia

News provided by

Vanda Pharmaceuticals Inc.

Jul 21, 2017, 07:00 ET